Impact Of Increased Drug Abuse On The Specimen Validity Testing Market Driver: Leading Transformation in the Specimen Validity Testing Market in 2025

What Are the Projected Growth and Market Size Trends for the Specimen Validity Testing Market?
The market size for specimen validity testing has shown significant growth lately. The projected growth is from $3.68 billion in 2024 to a larger $4.03 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 9.7%. The historical growth has been driven by factors such as escalated drug adoption, amplified drug screening, rigid regulations, heightened alcohol use, and incorporation of point-of-care testing.

It is anticipated that the specimen validity testing market will experience significant expansion in the upcoming years, ultimately reaching a value of $5.76 billion in 2029, with a compound annual growth rate (CAGR) of 9.3%. Factors such as the increasing need for workplace drug assessment, the widespread use of oral fluid testing, the surge in research and development activities, the escalating application of SVT, and the broadening use cases in pain management all contribute to this projected growth. Technological advances, the incorporation of artificial intelligence for analysis of results, product breakthroughs, a rise in collaborations, and the creation of mobile testing gadgets for real-time monitoring are the key trends to observe during the forecast period.

What Is Driving the Growth Trajectory of the Specimen Validity Testing Market?
The escalating levels of drug misuse are anticipated to drive the expansion of the specimen validity testing market in the future. Drug misuse is characterized by the common, excessive, or incorrect use of both legal and unauthorized substances for non-medical uses. The increase in drug misuse can be attributed to several intertwined factors including opioid addiction, rising mental health problems, lack of access to treatment and support services, and cultural portrayals. To detect the existence of contaminants and compounds, specimen validity testing (SVT) methods are employed, evaluating a variety of metrics such as pH levels, specific gravity, creatinine levels, and temperature. For instance, the Office for Health Improvement and Disparities, a government department based in the UK, reported in October 2023 that adult engagements with drug and alcohol programs increased from April 2021 to March 2022, reaching 0.29 million, a rise from 0.28 million in the previous year. Furthermore, according to the Office for National Statistics, a government agency also based in the UK, in October 2024, it was reported that there were 5,448 drug-poisoning related deaths in England and Wales in 2023, an 11.0% increase from the 4,907 deaths in 2022. Therefore, the surge in drug misuse is predicted to further accelerate the progress of the specimen validity testing market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15673&type=smp

Which Leading Companies Are Shaping the Growth of the Specimen Validity Testing Market?
Major companies operating in the specimen validity testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd

What Are the Major Trends Shaping the Specimen Validity Testing Market?
Leading firms involved in the specimen validity testing market are pursuing innovative product developments like high-definition urine drug testing profiles, to maintain their market dominance. A high-definition urine drug testing profile incorporates progressive analytical tactics. For example, Mayo Clinic Laboratories, an American medical lab, unveiled a data-driven urine drug testing (UDT) profile in July 2022. This tool is designed to provide physicians with crucial insights for managing patients grappling with dependencies on substances such as prescribed opioids, alcohol, marijuana, and nicotine. The fresh addiction medicine monitoring profile (Mayo ID ADMPU) is in line with the guidelines stipulated by the American Society of Addiction Medicine. It offers improved sensitivity and specificity for detecting original drugs and their metabolites across various drug classes, including opioids, benzodiazepines, stimulants, and PCP. This profile employs high-resolution, accurate mass spectrometry for targeted and immunoassay testing of particular substances, offering extensive and clinically pertinent data for healthcare providers.

What Are the Key Segments of the Specimen Validity Testing Market?
The specimen validity testing market covered in this report is segmented -

1) By Product And Service: Products, Service
2) By Testing Type: Laboratory Testing, Rapid Or Point-Of-Care Testing
3) By End-User: Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Criminal Justice And Law Enforcement Agencies, Other End-Users

Subsegments:
1) By Products: Reagents And Assay Kits, Controls And Calibrators, Specimen Collection Devices, Analyzers And Instruments
2) By Service: Laboratory Testing Services, Point-Of-Care Testing Services

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/specimen-validity-testing-global-market-report

Which Region Dominates the Specimen Validity Testing Market?
North America was the largest region in the specimen validity testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Specimen Validity Testing Global Market Report?

- Market Size Analysis: Analyze the Specimen Validity Testing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Specimen Validity Testing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Specimen Validity Testing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Specimen Validity Testing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15673

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.